• MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Infographic: Patient Concerns With Biosimilar Substitution

A recent survey of 588 Canadian patients revealed that many patients had serious concerns about biosimilar substitution.

A recent survey of 588 Canadian patients revealed that many patients had serious concerns about biosimilar substitution.

Related Content:

PracticePolicy
New Data Support Hulio as an Interchangeable Adalimumab Option
European Data Confirm Real-World Benefits of Adalimumab Biosimilars
Boosting Biosimilar Use in Osteoporosis: Why HCP Education Matters